ストックスクリーナーアプリを入手
3.5694
4.05%
-0.1507
前日終値:
$3.7201
開ける：
$3.65
24時間の取引高:
2,169
Relative Volume:
0.43
時価総額：
$131.62M
収益：
$7.80M
当期純損益:
$-69.02M
株価収益率:
-1.6669
EPS:
-2.1413
ネットキャッシュフロー:
$-66.61M
1週間 パフォーマンス:
-21.78%
1か月 パフォーマンス:
-23.73%
6か月 パフォーマンス:
-28.90%
1年 パフォーマンス:
-8.71%
1日の値動き範囲:
$3.5694
$4.02
1週間の範囲:
$3.5694
$4.50
52週間の値動き範囲:
$3.32
$12.70
Molecular Partners Ag Adr Stock (MOLN) Company Profile
MOLN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MOLN
Molecular Partners Ag Adr
|
3.5694 | 131.62M | 7.80M | -69.02M | -66.61M | -2.1413 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-30 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-08-29 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-25 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2022-04-27 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2021-07-13 | 開始されました | Cowen | Outperform |
| 2021-07-12 | 再開されました | SVB Leerink | Outperform |
すべてを表示
Molecular Partners Ag Adr (MOLN) 最新ニュース
Can Contango ORE, Inc. (CTGO) Climb 163.28% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Musk's DOGE Exit Rumors & Weak Q1 Deliveries: How to Play Tesla Now - Yahoo Finance
Why Tractor Supply (TSCO) is a Top Momentum Stock for the Long-Term - Yahoo Finance
TD Cowen maintains Buy on Molecular Partners, target CHF15 - Investing.com India
Molecular Partners reports 2024 annual results - Investing.com India
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024 - GlobeNewswire Inc.
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Here's Why Seagate (STX) is a Strong Momentum Stock - Yahoo Finance
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M - TipRanks
Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks
Molecular Partners expands 212Pb co-development agreement with Orano Med - TipRanks
Molecular Partners shares gain on Leerink's outperform rating - Investing.com
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
US stock market gainers for the last week of April 2022 - Nairametrics
Novartis to push forward with covid drug after positive results - Luxembourg Times
Wall Street Analysts See a 96% Upside in Molecular Partners AG Sponsored ADR (MOLN): Can the Stock Really Move This High? - Yahoo Finance
Citi Appointed as Depositary Bank for Molecular Partners AG’s ADR Programme - Business Wire
Market Data Center - Barron's
Molecular Partners Ag Adr (MOLN) 財務データ
収益
当期純利益
現金流量
EPS
3.01%
大文字化:
|
ボリューム (24 時間):